Lianyungang, China

Yizhong Zhu

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Lianyungang, CN (2018 - 2020)
  • Jiangsu, CN (2019 - 2021)

Company Filing History:


Years Active: 2018-2025

where 'Filed Patents' based on already Granted Patents

6 patents (USPTO):

Title: Yizhong Zhu: Innovator in Pharmaceutical Chemistry

Introduction

Yizhong Zhu is a prominent inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific diseases. With a total of six patents to his name, Zhu's work is recognized for its potential impact on medical treatments.

Latest Patents

Zhu's latest patents include a trifluoromethyl-substituted sulfonamide as a BCL-2-selective inhibitor. This invention discloses a compound that can be used to treat anti-apoptotic BCL-2-related diseases, such as cancer. Another notable patent is a macrocycle containing aminopyrazole and pyrimidine, which is designed to inhibit tropomyosin receptor kinase (Trk) activity. This compound has potential applications in treating diseases mediated by Trk in mammals.

Career Highlights

Throughout his career, Yizhong Zhu has worked with several notable companies, including Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Centaurus Biopharma Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical research.

Collaborations

Zhu has collaborated with various professionals in his field, including colleagues such as Fei Liu and Lulu Wang. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Yizhong Zhu is a distinguished inventor whose work in pharmaceutical chemistry has the potential to revolutionize treatments for serious diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…